These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7890671)

  • 1. Crystal structures of recombinant rat cathepsin B and a cathepsin B-inhibitor complex. Implications for structure-based inhibitor design.
    Jia Z; Hasnain S; Hirama T; Lee X; Mort JS; To R; Huber CP
    J Biol Chem; 1995 Mar; 270(10):5527-33. PubMed ID: 7890671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The refined 2.15 A X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity.
    Musil D; Zucic D; Turk D; Engh RA; Mayr I; Huber R; Popovic T; Turk V; Towatari T; Katunuma N
    EMBO J; 1991 Sep; 10(9):2321-30. PubMed ID: 1868826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of recombinant rat cathepsin B and nonglycosylated mutants expressed in yeast. New insights into the pH dependence of cathepsin B-catalyzed hydrolyses.
    Hasnain S; Hirama T; Tam A; Mort JS
    J Biol Chem; 1992 Mar; 267(7):4713-21. PubMed ID: 1537854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative evaluation of each catalytic subsite of cathepsin B for inhibitory activity based on inhibitory activity-binding mode relationship of epoxysuccinyl inhibitors by X-ray crystal structure analyses of complexes.
    Watanabe D; Yamamoto A; Tomoo K; Matsumoto K; Murata M; Kitamura K; Ishida T
    J Mol Biol; 2006 Oct; 362(5):979-93. PubMed ID: 16950396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and alteration of the S2 subsite of the Leishmania major cathepsin B-like cysteine protease.
    Chan VJ; Selzer PM; McKerrow JH; Sakanari JA
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):113-7. PubMed ID: 10229665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of cathepsin B specificity by site-directed mutagenesis. Importance of Glu245 in the S2-P2 specificity for arginine and its role in transition state stabilization.
    Hasnain S; Hirama T; Huber CP; Mason P; Mort JS
    J Biol Chem; 1993 Jan; 268(1):235-40. PubMed ID: 8093241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate specificity of bovine cathepsin B and its inhibition by CA074, based on crystal structure refinement of the complex.
    Yamamoto A; Tomoo K; Hara T; Murata M; Kitamura K; Ishida T
    J Biochem; 2000 Apr; 127(4):635-43. PubMed ID: 10739956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structures of the recombinant β-factor XIIa protease with bound Thr-Arg and Pro-Arg substrate mimetics.
    Pathak M; Manna R; Li C; Kaira BG; Hamad BK; Belviso BD; Bonturi CR; Dreveny I; Fischer PM; Dekker LV; Oliva MLV; Emsley J
    Acta Crystallogr D Struct Biol; 2019 Jun; 75(Pt 6):578-591. PubMed ID: 31205020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2.2 A crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificity.
    Pereira PJ; Wang ZM; Rubin H; Huber R; Bode W; Schechter NM; Strobl S
    J Mol Biol; 1999 Feb; 286(1):163-73. PubMed ID: 9931257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The binding mode of an E-64 analog to the active site of cathepsin B.
    Feng MH; Chan SL; Xiang Y; Huber CP; Lim C
    Protein Eng; 1996 Nov; 9(11):977-86. PubMed ID: 8961350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An enormously active and selective azapeptide inhibitor of cathepsin B.
    Wieczerzak E; Rodziewicz-Motowidło S; Jankowska E; Giełdoń A; Ciarkowski J
    J Pept Sci; 2007 Aug; 13(8):536-43. PubMed ID: 17617796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of porcine cathepsin H determined at 2.1 A resolution: location of the mini-chain C-terminal carboxyl group defines cathepsin H aminopeptidase function.
    Guncar G; Podobnik M; Pungercar J; Strukelj B; Turk V; Turk D
    Structure; 1998 Jan; 6(1):51-61. PubMed ID: 9493267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular dynamics simulations of bovine cathepsin B and its complex with CA074.
    Yamamoto A; Tomoo K; Miyagawa H; Takaoka Y; Sumiya S; Kitamura K; Ishida T
    Chem Pharm Bull (Tokyo); 2000 Apr; 48(4):480-5. PubMed ID: 10783065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH Dependence of inhibitors targeting the occluding loop of cathepsin B.
    Cathers BE; Barrett C; Palmer JT; Rydzewski RM
    Bioorg Chem; 2002 Aug; 30(4):264-75. PubMed ID: 12392705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships.
    Bode W; Turk D; Karshikov A
    Protein Sci; 1992 Apr; 1(4):426-71. PubMed ID: 1304349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular design of potent inhibitor specific for cathepsin B based on the tertiary structure prediction.
    Sumiya S; Yoneda T; Kitamura K; Murata M; Yokoo C; Tamai M; Yamamoto A; Inoue M; Ishida T
    Chem Pharm Bull (Tokyo); 1992 Feb; 40(2):299-303. PubMed ID: 1606628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of cathepsin B to fluorescent substrates containing benzyl side-chain-substituted amino acids at P1 subsite.
    Del Nery E; Alves LC; Melo RL; Cesari MH; Juliano L; Juliano MA
    J Protein Chem; 2000 Jan; 19(1):33-8. PubMed ID: 10882170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystatin inhibition of cathepsin B requires dislocation of the proteinase occluding loop. Demonstration By release of loop anchoring through mutation of his110.
    Pavlova A; Krupa JC; Mort JS; Abrahamson M; Björk I
    FEBS Lett; 2000 Dec; 487(2):156-60. PubMed ID: 11150500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the interaction of valine-10 in cystatin C with the S2 subsite of cathepsin B.
    Lindahl P; Ripoll D; Abrahamson M; Mort JS; Storer AC
    Biochemistry; 1994 Apr; 33(14):4384-92. PubMed ID: 8155656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of rat procathepsin B: model for inhibition of cysteine protease activity by the proregion.
    Cygler M; Sivaraman J; Grochulski P; Coulombe R; Storer AC; Mort JS
    Structure; 1996 Apr; 4(4):405-16. PubMed ID: 8740363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.